Testing the Feasibility of an Online Guided-writing Intervention Designed for Informal Caregivers of People With Parkinson's Disease
Single-group Feasibility Study and Process Evaluation of a Guided Reflective Writing Intervention for Informal Caregivers of People With Parkinson's Disease
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Reading, United Kingdom, RG6 6ES
- School of Psychology and Clinical Language Sciences
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria: provides unpaid, community-based and non-institutional care to a person with Parkinson's disease -
Exclusion Criteria: paid and/or professional caregivers, or those providing care to someone in an institutional setting
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: Experience intervention
All caregiver's experienced the intervention
|
Four writing exercises that can be completed at the caregiver's convenience, albeit a maximum of one exercise per day.
Caregivers can also use a 'save and return function' so do not have to write continuously and complete in one sitting
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
State and Trait Anxiety Inventory
Time Frame: Pre- and post-intervention; which is completion of the four intervention exercises, an average of 20 days; two-week follow-up
|
20-item measure
|
Pre- and post-intervention; which is completion of the four intervention exercises, an average of 20 days; two-week follow-up
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-compassion Scale
Time Frame: Pre- and post-intervention; which is completion of the four intervention exercises, an average of 20 days; two-week follow-up
|
Neff's 26 item scale
|
Pre- and post-intervention; which is completion of the four intervention exercises, an average of 20 days; two-week follow-up
|
|
Emotional Regulation Questionnaire
Time Frame: Pre- and post-intervention, which is completion of the four intervention exercises, an average of 20 days; two-week follow-up
|
ten-item version
|
Pre- and post-intervention, which is completion of the four intervention exercises, an average of 20 days; two-week follow-up
|
|
Positive and Negative Affect Scale-Extended version
Time Frame: Pre- and post-intervention, which is completion of the four intervention exercises, an average of 20 days; two-week follow-up
|
Guilt and Serenity subscales only
|
Pre- and post-intervention, which is completion of the four intervention exercises, an average of 20 days; two-week follow-up
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Aileen K Ho, PhD, University of Reading
- Study Director: Jacqueline Sin, PhD, The Hong Kong Polytechnic University
- Principal Investigator: Neil Boyt, MSc, University of Reading
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2024-086-AH
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.